8-K ·Filed Jun 18, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine executive departure with no immediate financial or operational implications. Monitor for announcement of a successor, but no trading action warranted.
Final — all horizons settled through T+60d
HCA ▲ +13.41% at T+60d
NEUTRAL call ✓ call won +13.41% · α vs SPY +11.52% · entry $375.17 → $425.49
T+1d
+0.49%
call +0.49% · α +0.80%
$376.99
settled 3mo ago
T+5d
+3.14%
call +3.14% · α +4.80%
$386.94
settled 3mo ago
T+20d
+2.82%
call +2.82% · α +2.28%
$385.74
settled 2mo ago
T+60d
+13.41%
call +13.41% · α +11.52%
$425.49
settled 17d ago
Price Chart
Loading chart...
Executive Summary
HCA Healthcare announced that Dr. Michael Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and remain in a transitional role until February 2027. This is a routine non-CEO departure with no financial impact or red flags.
Key Facts
- Dr. Michael Cuffe to step down as EVP and Chief Clinical Officer effective August 31, 2026
- Will continue in a transitional role until February 2027
- Eligible for benefits per executive severance policy and incentive plans
- No replacement named in the filing
Financial Impact
No financial impact disclosed
Market Snapshot
Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
63% bullish (30 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-275086 |
| Document: 0001193125-26-275086-index-headers.html | 0001193125-26-275086 |
| Document: 0001193125-26-275086-index.html | 0001193125-26-275086 |
| Document: 0001193125-26-275086.txt | 0001193125-26-275086 |
8 reports for HCA
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 24, 2026 10w ago | 8-K | $382.19 $429.19 | ▲ +12.30% | ▲ +8.67% | $426.11 (+11.49%) |
Jul 14, 2026 11w ago | 8-K | $363.60 $411.44 | ▼ −13.16% | ▼ −10.67% | $426.11 (−17.19%) |
Jun 18, 2026 15w ago | 8-K | $375.17 $385.74 | ▲ +2.82% | ▲ +2.28% | $426.11 (+13.58%) |
Apr 27, 2026 22w ago | 8-K | $431.48 $392.42 | ▼ −9.05% | ▼ −14.52% | $426.11 (−1.25%) |
Apr 27, 2026 22w ago | Court Ruling | $445.70 $392.48 | ▼ −11.94% | ▼ −16.87% | $426.11 (−4.39%) |
Apr 24, 2026 23w ago | 8-K | $432.55 $392.56 | ▼ −9.25% | ▼ −13.27% | $426.11 (−1.49%) |
Mar 13, 2026 28w ago | DEFA14A | $525.04 $496.74 | ▼ −5.39% | ▼ −9.17% | $426.11 (−18.84%) |
Feb 25, 2026 31w ago | 8-K | $525.78 $479.78 | ▼ −8.75% | ▼ −2.35% | $426.11 (−18.96%) |
Showing 8 of 8
US Market Status
Market Open — Closes in 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access